0 items USD 0.00Search
- Did you mean
- endothelial carcinoma
Your search for "urothelial carcinoma" gave back 326 results.
The global Hurthle Cell Carcinoma Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
The adrenocortical carcinoma drugs market has recorded the development of several advanced imaging techniques, which are non-invasive and exhibit...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Kidney cancer/ renal cell carcinoma (RCC) is among ten most commonly observed cancer these days. It is sixth common cancer observed in men and it is...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Merkel cell carcinoma treatment includes medical interventions and therapies used to manage Merkel cell carcinoma, a rare and aggressive skin cancer...
Catalog:
MRRPB5
November 2023
Price: USD 3,350.00
Merkel cell carcinoma (MCC) is a rare and aggressive neuroendocrine tumor of the skin. Market Analysis and Insights: Global Merkel Cell Carcinoma...
Catalog:
MRRPB5
August 2023
Price: USD 4,900.00
Market Analysis and Insights: Global Unresectable Hepatocellular Carcinoma Treatment Market The global Unresectable Hepatocellular Carcinoma...
Catalog:
MRRPB5
July 2023
Price: USD 4,900.00
Market Analysis and Insights: Global Thymic Carcinoma Treatment Market The global Thymic Carcinoma Treatment market is projected to grow from US$...
Catalog:
MRRPB5
August 2023
Price: USD 4,900.00
Market Analysis and Insights: Global Neuroendocrine Carcinoma Treatment Market The global Neuroendocrine Carcinoma Treatment market is projected to...
Catalog:
MRRPB5
June 2023
Price: USD 4,900.00
The global Neuroendocrine Carcinoma Drugs market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth...
Catalog:
MRRPB5
June 2023
Price: USD 4,900.00
The global Basal Cell Carcinoma Drug market size is expected to reach $ 861 million by 2029, rising at a market growth of 8.2% CAGR during the...
Catalog:
GIR
July 2023
Price: USD 4,480.00
Basal cell carcinoma (BCC) is the most common type of skin cancer. It’s also the most commonly diagnosed cancer in the United States. Every year,...
Catalog:
MRRPB5
July 2023
Price: USD 2,900.00
The most effective targeted drug introduced for HCC has been sorafenib. Sorafenib, a multi-tyrosine kinase inhibitor (TKI), remains the only systemic...
Catalog:
MRRPB5
July 2023
Price: USD 4,900.00
Market Analysis and Insights: Global Renal Cell Carcinoma Clinical Trial Pipeline Market The global Renal Cell Carcinoma Clinical Trial Pipeline...
Catalog:
MRRPB5
August 2023
Price: USD 4,900.00
Gastric Carcinomas is a cancer of the gastric mucosa. Early symptoms include heartburn, upper abdominal pain, nausea, and loss of appetite. Symptoms...
Catalog:
MRRPB5
July 2023
Price: USD 4,900.00
Neuroendocrine tumors (NETs) are neoplasms that arise from cells of the endocrine (hormonal) and nervous systems. Many are benign, while some are...
Catalog:
MRRPB5
June 2023
Price: USD 4,900.00
